Skip to main content
NIH funding notice RFA-DA-25-031

Adolescent Overdose Prevention and SUD Treatment Initiative (R34 - Clinical Trial Optional)

Closed on March 13, 2024.

Posted
November 17, 2023
Close date
March 13, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,149,043 in first-year total cost, median $574,522.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 CEM-E (O1)]2

Most frequent institutions

  1. MARYLAND TREATMENT CENTERS, INC.1
  2. UNIVERSITY OF BRITISH COLUMBIA1
Competing awards under RFA-DA-25-031 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD adherence to adolescents with OUD1R34DA062260-01FISHMAN, MARCWENZEL, KEVIN R.MARYLAND TREATMENT CENTERS, INC., MD$576,675ZDA1
2024Adapting and Testing a Youth Overdose Prevention Toolkit1R34DA062280-01FAST, DANYAHADLAND, SCOTT EVANUNIVERSITY OF BRITISH COLUMBIA, BC$572,368ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.